SCHEMBL25927403

SCHEMBL25927403

Cc1ccc2c(=O)n(N)ccc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 3/20 0.43
LMNA P02545 2/20 0.43
GAA P10253 2/20 0.43
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CYP1A2 P05177 3/20 0.41
CYP2A6 P11509 2/20 0.38
GLA P06280 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
MAOB P27338 1/20 0.35
P2RY2 P41231 1/20 0.34
CA12 O43570 2/20 0.34
CA9 Q16790 2/20 0.34
CCNE2 O96020 2/20 0.34
CDK4 P11802 2/20 0.34
CCND1 P24385 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7601676 0.79 MEN1 (0.49) KMT2AMEN1ALDH1A1KDM4ELMNA
SCHEMBL29809554 0.79 MEN1 (0.49) KMT2AMEN1ALDH1A1KDM4ELMNA
SCHEMBL24225329 0.78 KDM4E (0.43) KMT2AMEN1ALDH1A1KDM4ELMNA
SCHEMBL13948718 0.75 MEN1 (0.46) KMT2AMEN1ALDH1A1KDM4ELMNA
SCHEMBL22166697 0.75 MEN1 (0.43) KMT2AMEN1ALDH1A1KDM4ELMNA
SCHEMBL21391523 0.75 MEN1 (0.43) KMT2AMEN1ALDH1A1KDM4ELMNA
SCHEMBL10273425 0.75 GRM2 (0.43) KMT2AMEN1ALDH1A1KDM4ELMNA
SCHEMBL4069129 0.75 MEN1 (0.43) KMT2AMEN1ALDH1A1KDM4ELMNA
SCHEMBL20808748 0.73 LMNA (0.46) KMT2AMEN1ALDH1A1KDM4ELMNA
SCHEMBL30349755 0.72 ALDH1A1 (0.40) KMT2AALDH1A1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023109892-A1 COMPOUND FOR INHIBITING OR DEGRADING BRD9, AND COMPOSITION AND PHARMACEUTICAL USE THEREOF 海思科医药集团股份有限公司 2023-06-22 WO disclosed